We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Surveillance Trial Offers Peace of Mind for High-risk BRCA-carriers

News   Aug 23, 2018 | Original story sourced from University College Hospitals London

 
Avoiding Late Diagnosis of Ovarian Cancer

The ALDO (Avoiding Late Diagnosis of Ovarian Cancer) project is a partnership between UCLH Cancer Collaborative and Abcodia Ltd. The project was conceived as part of the Cancer Vanguard’s challenge to industry in 2017, to work with the NHS on projects to improve the early diagnosis of cancer. Photo credit: Pixabay

 
 
 

RELATED ARTICLES

A Blood Test for Drowsy Driving

News

Blood test could help assess pilots' fitness to fly, and help police identify drowsy drivers in traffic accidents.

READ MORE

Shaping the Cancer Fight with Immune Cells

News

Researchers at Case Western Reserve University have discovered how to quickly and accurately predict which lung cancer patients will benefit from chemotherapy by analyzing how immune cells the body sends out to fight the disease are arranged.

READ MORE

Cytokine Signature Helps Target Advanced Breast Cancer

News

A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE